Table 1.

Summary of demographic information for the subjects in the Janssen study [18] and the patients in the VAL401 study

Parameter	Subjects in the Janssen study [18]						Lung-cancer patients administered VAL401 in the present study
	Young (count and mean ± SD)	Elderly (count and mean ± SD)	Liver disease (count and mean ± SD)	Moderate renal disease (count and mean ± SD)	Severe renal disease (count and mean ± SD)	All patients (count and mean)
No. of subjects	8	12	8	7	7	42	8
Gender
Male	5	7	3	3	4	22	5
Female	3	5	5	4	3	20	3
Age (years)	30 ± 4	69 ± 4	51 ± 12	56 ± 13	52 ± 13	52	65.8 ± 9
Age range (years)	25–35	65–78	35–73	34–68	29–66	38–64	54–76
Weight (kg)	78 ± 19	78 ± 16	85 ± 17	82 ± 18	78 ± 20	80	68.3 ± 9
Height (cm)	172 ± 15	169 ± 10	166 ± 11	170 ± 15	174 ± 9	170	169 ± 7